American Heart Journal

Papers
(The H4-Index of American Heart Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms161
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study160
Table of Contents92
Table of Contents82
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial72
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease68
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study64
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism51
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF50
Editorial Board48
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial47
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes40
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network39
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network39
Information for Readers36
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function36
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e35
Information for Readers34
The trial to assess chelation therapy 2 (TACT2): Rationale and design34
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial34
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study33
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections33
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer33
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States32
Physician responses to apple watch-detected irregular rhythm alerts32
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings29
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER28
Cardiac auscultation skills among medical trainees28
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients28
0.072983980178833